Clinical Trials Sponsored by Viramal Limited

Total 2935 results

Viramal Limited

Completed

Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women

Vaginal Atrophy

United States
Viramal Limited

Completed

Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy

Endometriosis

Italy
Viramal Limited
Simbec Research

Recruiting

Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

Menopause

United Kingdom
Piramal Imaging Limited

Completed

Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD

Alzheimer's Disease (AD)

France
Piramal Enterprises Limited

Suspended

Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

United States, India
Piramal Enterprises Limited

Suspended

Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

United States, India
Piramal Enterprises Limited

Terminated

A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin

Breast Cancer

United States
Piramal Enterprises Limited

Terminated

A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer (SPARK)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Completed

A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies (Serenity)

Solid Tumor | Hematologic Malignancy

India
Piramal Enterprises Limited

Completed

A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00

Radiation Induced Mucositis in Head and Neck Cancer

India
Piramal Enterprises Limited

Completed

A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer (MONARCH)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Terminated

Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects

Healthy, Overweight and/or Obese Subjects

India
Piramal Enterprises Limited

Terminated

Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain

Acute Dental Pain
Piramal Enterprises Limited

Completed

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

India
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer (SAVIOR)

Pancreatic Cancer

India
Piramal Enterprises Limited

Completed

Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

Canada, India
Piramal Enterprises Limited

Completed

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (ENVER)

Melanoma

Australia, India, New Zealand
Piramal Enterprises Limited

Completed

A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

Plaque Psoriasis

India
Piramal Enterprises Limited

Completed

A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies

Cancer

Canada
Piramal Enterprises Limited

Terminated

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States, India
Piramal Enterprises Limited

Withdrawn

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

Multiple Myeloma
Piramal Enterprises Limited

Terminated

Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

India
Niramai Health Analytix Private Limited
Max Healthcare Insititute Limited

Completed

A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers

Breast Cancer | Early Detection of Cancer

India
Piramal Enterprises Limited
Melanoma Research Foundation Breakthrough Consortium

Suspended

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Advanced or Inoperable Malignant Melanoma With BRAF Mutation

United States
Piramal Enterprises Limited
Quintiles, Inc.; Miami Research Associates

Unknown

Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187

Overweight | Diabetes Mellitus Type 2 in Obese

United States
Piramal Enterprises Limited
Profil Institute for Clinical Research, Inc.

Completed

Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects

Healthy

United States
Piramal Enterprises Limited
Dana-Farber Cancer Institute; Norris Cotton Cancer Center

Suspended

Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

United States
Piramal Critical Care, Ltd.

Completed

Safety and Efficacy Study of Hydromorphone Hydrochloride by Intrathecal Administration

Management of Chronic Pain

United States
Piramal Critical Care, Ltd.

Completed

Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump

Severe Spasticity

United States
Piramal Healthcare Canada Ltd

Completed

Follow-Up Study Evaluating The Long Term Safety and Efficacy of BST-CarGel and Microfracture Repair of the Knee

Knee Injuries

Spain, Canada
Piramal Critical Care, Ltd.

Completed

Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration

Chronic Pain

United States
Piramal Healthcare Canada Ltd

Completed

Trial Comparing BST-CarGel and Microfracture in Repair of Articular Cartilage Lesions in the Knee

Knee Injuries

Korea, Republic of, Canada, Spain
Miramar Labs

Completed

A Prospective Study of Axillary Hair Loss in Patients Treated With the miraDry System

Underarm Hair

United States
Miramar Labs

Completed

Clinical Evaluation of the miraDry System in Subjects With Hyperhidrosis

Axillary Hyperhidrosis

Canada
Miramar Labs

Completed

Efficacy and Safety of the DTS-G2 System in Patients With Axillary Hyperhidrosis (DRI-UP)

Primary Focal Hyperhidrosis, Axilla

United States
Medaphor Limited
IntelligentUltrasound Limited

Completed

A Volunteer Study to Collect Imaging Data for the Development of the ntelligentUltrasound Anatomy Guide

Ultrasound Imaging of Anatomical Structures

United Kingdom
Heptares Therapeutics Limited
P1vital Limited

Completed

Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects

Alzheimer's Disease

United Kingdom
GlaxoSmithKline
Piramal Clinical Research (Hyderabad, India)

Completed

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions

Ulcers, Duodenal and Gastric

India
GlaxoSmithKline
Piramal Clinical Research (Hyderabad, India)

Completed

Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions

Ulcers, Duodenal and Gastric

India
pSiVida Limited
pSiOncology Private Limited

Unknown

Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma

Liver Cancer

Singapore
Exonate Limited
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety and Tolerability of EXN407

Diabetic Macular Edema

Australia
Clinuvel Europe Limited

Recruiting

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

Xeroderma Pigmentosum

Germany
SpyBiotech Limited

Recruiting

A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants (SPYVAC01)

Cytomegalovirus Infections

United Kingdom
Medibio Limited

Recruiting

Sleep Signal Analysis for Current Major Depressive Episode (SAMDE) (SAMDE)

Depressive Disorder | Depression | Depressive Disorder, Major | Depressive Episode | Depression Mild

United States
CroiValve Limited

Recruiting

A Feasibility Study of the CroíValve DUO System for Tricuspid Regurgitation (TANDEM I)

Tricuspid Regurgitation

Poland
Novoic Limited

Not yet recruiting

Prediction of Amyloid and Mild Cognitive Impairment in Early Stage Alzheimer's Disease From Remote Speech Phenotyping (EARS)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer's Disease (Incl Subtypes)
BicycleTx Limited

Recruiting

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Carcinoma, Non-Small-Cell Lung | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Ovarian Neoplasm | Urinary Bladder Neoplasm

United States, United Kingdom, France, Spain, Italy, Canada
BicycleTx Limited

Recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

Head and Neck Cancer | Ovarian Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced Solid Tumor Historically Known for High EphA2 Expression | Urothelial Cancer | Gastric/Upper Gastrointestinal Cancer

United States, Belgium, Korea, Republic of, Spain, United Kingdom
Laekna Limited

Active, not recruiting

Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian (PROFECTA-II)

Platinum-resistant Ovarian Cancer

United States, China

3

Subscribe